What lat­est wave of lay­offs means for biotech; Ra­dio­ther­a­py short­age; De­liv­er­ing on mR­NA's promis­es; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Nom­i­na­tions are now open for a spe­cial re­port that will high­light the con­tri­bu­tions of LGBTQ+ bio­phar­ma lead­ers. Let us know who we should con­sid­er — our main ask is that you make the nom­i­na­tions per­son­al.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER